Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 6,201–6,228 of 6,228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00116389	Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas	terminated	Phase 2	60	Point TherapeuticsINDUSTRY	1	Jun 8, 2007	clinicaltrials
NCT00316433	Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer	terminated	Phase 2	24	Swedish Medical CenterOTHER	1	Apr 5, 2007	clinicaltrials
NCT00076609